Fisetin derivatives exhibit enhanced anti-inflammatory activity and modulation of endoplasmic reticulum stress
•Inflammation attempts to restore homeostasis upon infection or injury.•Compromised homeostasis builds up to endoplasmic reticulum (ER) stress.•Both signaling mechanisms can be deleterious and characterize chronic diseases.•Fisetin is a dietary flavanol that possesses remarkable bioactivity.•Fisetin...
Gespeichert in:
Veröffentlicht in: | International immunopharmacology 2023-06, Vol.119, p.110178-110178, Article 110178 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Inflammation attempts to restore homeostasis upon infection or injury.•Compromised homeostasis builds up to endoplasmic reticulum (ER) stress.•Both signaling mechanisms can be deleterious and characterize chronic diseases.•Fisetin is a dietary flavanol that possesses remarkable bioactivity.•Fisetin and reported derivatives are modulators of inflammation and ER stress.
Inflammation and endoplasmic reticulum (ER) stress are often hand in hand in the context of chronic disease. Both are activated upon perceived disturbances in homeostasis, being deleterious when intensely or chronically activated. Fisetin (FST) is a dietary flavonol that is known to possess multiple relevant bioactivities, raising the question of its potential health benefits and even its use in novel pharmacological approaches against ER stress and inflammation. To attain this prospect, some limitations to this molecule, namely its poor bioavailability and solubility, must be addressed.
In an attempt to improve the biological properties of the parent molecule, we have synthesized a set of FST derivatives. These new molecules were tested along with the original compound for their ability to mitigate the activation of the signaling pathways underlying inflammation and ER stress. By reducing LPS-induced nuclear factor-kappa B (NF-κB) activation, cytokine release, inflammasome activation and reactive oxygen species (ROS) generation, FST has proven to be effective against the onset of inflammation. The molecule also decreases the activation of the unfolded protein response (UPR), as evidenced by the reduced expression of relevant UPR-related genes upon ER stress induction. Some of the tested derivatives are novel inhibitors of targets associated to inflammation and ER stress signaling, in some cases more potent than the parent compound. Furthermore, the reduced cytotoxicity of some of these molecules enabled the use of higher concentrations than that of FST, resulting in the observation of enhanced bioactivities. |
---|---|
ISSN: | 1567-5769 1878-1705 |
DOI: | 10.1016/j.intimp.2023.110178 |